 |
|
Marta Janer
Area of Expertise
Genetics
Current Position
Director of Genotyping Facility
Degree
Ph.D., Immunogenetics, University of Oxford, 1995
Research Interests
Dr. Janer is interested in understanding the genetic component of complex diseases through the use of high throughput technologies coupled with data mining and data integration methods. The identification of such genes is the first step towards the development of a preventive and personalized medicine.
Selected Publications
Hawn TR, Verbon A, Janer M, Zhao LP, Beutler B, Aderem A. Toll-like receptor 4 polymorphisms are associated with resistance to Legionnaires' disease. 2005. Proc Natl Acad Sci U S A. 102(7):2487-2489
Janer M , Fredrichsen D, Stanford J-L, Badzioch M, Kolb S, Deutsch K, Peters M, Goode EL, Welti R, DeFrance HB, Iwasaki L, Li S, Hood L, Ostrander E, Jarvik G. Genomic Scan of 254 hereditary prostate cancer families. 2003. Prostate, 57(4): 309-319
Gibbs M, Stanford JK, Jarvik GP, Janer M, Badzioch M., Peters MA, Goode EL, Kolb S, Chakrabati L, Shook M, Basom R, Ostrander EA, Hood L. A genomic scan of families with prostate cancer identifies multiple regions of interest. 2000. Am. J. Hum. Genet. 67:100-109
Guillaudeux T, Janer M, Bubb K, Spies T, and Geraghty DE. The complete genomic sequence of 424,015 bp at the centromeric end of the HLA class I region: gene content and polymorphism. 1998. Proc Natl Acad Sci USA 95:9494-9
Janer M and Geraghty DE. The human major histocompatibility complex: 42,221 bp of genomic sequence, high density sequence-tagged site map, evolution, and polymorphism for HLA class I. 1998. Genomics 51:35-44
|
|
|
home
